Robertson, R M <br/><br/>
Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.  [electronic resource] 

 -  The New England journal of medicine  Apr 1981 
 - 998-1003 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM198104233041703  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angina Pectoris--etiology<br/>Angina Pectoris, Variant--blood<br/>Arteries<br/>Aspirin--pharmacology<br/>Clinical Trials as Topic<br/>Coronary Circulation<br/>Coronary Vessels<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Indomethacin--pharmacology<br/>Ischemia--epidemiology<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Thromboxane A2--physiology<br/>Thromboxane B2--analogs & derivatives<br/>Thromboxanes--physiology<br/>Time Factors<br/>Veins